Holen Sie sich die Stockscreener-App
45.61
0.16%
-0.0682
Schlusskurs vom Vortag:
$45.68
Offen:
$45.58
24-Stunden-Volumen:
2.27M
Relative Volume:
1.27
Marktkapitalisierung:
$8.59B
Einnahmen:
$550.17M
Nettoeinkommen (Verlust:
$201.35M
KGV:
45.61
EPS:
1
Netto-Cashflow:
$232.07M
1W Leistung:
-9.80%
1M Leistung:
-16.00%
6M Leistung:
-21.45%
1J Leistung:
-15.28%
1-Tages-Spanne:
$44.98
$46.16
1-Wochen-Bereich:
$44.98
$51.80
52-Wochen-Spanne:
$44.98
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
45.65 | 8.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
232.04 | 39.30B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.36 | 13.71B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
93.41 | 7.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.35 | 6.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year! - Smartkarma
Doximity (DOCS) Gains Overweight Rating from Barclays | DOCS Sto - GuruFocus
Rep. Jonathan L. Jackson Sells Doximity, Inc. (NASDAQ:DOCS) Shares - MarketBeat
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching - Yahoo Finance
Illinois Rep. Jonathan Jackson Sold Up to $80K Worth of Doximity Stock - Benzinga
Doximity: Strong Quarter Overshadowed By Policy-Driven Budget Uncertainty (NYSE:DOCS) - Seeking Alpha
Doximity stock holds steady as Wells Fargo maintains Equal Weight rating By Investing.com - Investing.com Canada
Doximity stock holds steady as Wells Fargo maintains Equal Weight rating - Investing.com
New York State Common Retirement Fund Reduces Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity: Elite Margins, AI Growth, And An Attractive Multiple (NYSE:DOCS) - Seeking Alpha
Doximity (NASDAQ:DOCS) Trading Down 10.5%Here's What Happened - MarketBeat
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com
Doximity (NASDAQ:DOCS) Hits New 52-Week LowShould You Sell? - MarketBeat
Here’s How Doximity (DOCS) Regained Investors’ Trust - MSN
Oversold Conditions For Doximity (DOCS) - Nasdaq
Doximity stock hits 52-week low at 45.96 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 45.96 USD - Investing.com India
Hsbc Holdings PLC Trims Holdings in Doximity, Inc. $DOCS - MarketBeat
Will Doximity Inc. stock deliver strong dividend growthWeekly Profit Report & Proven Capital Preservation Methods - Newser
How risky is Doximity Inc. Class stock compared to peers2025 Biggest Moves & Verified Entry Point Detection - Newser
Arrowstreet Capital Limited Partnership Lowers Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Doximity (DOCS) director logs option exercise and 2,000-share sale in Form 4 - Stock Titan
Doximity, Inc. $DOCS Shares Sold by Skandinaviska Enskilda Banken AB publ - MarketBeat
Capital Fund Management S.A. Takes Position in Doximity, Inc. $DOCS - MarketBeat
Edgestream Partners L.P. Buys 38,540 Shares of Doximity, Inc. $DOCS - MarketBeat
DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Why Doximity Inc. stock remains on buy listsNew Guidance & Verified Momentum Stock Watchlist - Newser
Will Doximity Inc. Class stock outperform benchmarksWeekly Trade Review & AI Enhanced Market Trend Forecasts - Newser
Will Doximity Inc. Class stock enhance shareholder value - Newser
Can Doximity Inc. Class stock ride next bull market cycleBond Market & Real-Time Stock Price Movement Reports - Newser
Doximity (DOCS) insider files Form 144 to sell 2,000 common shares - Stock Titan
Doximity: Strong Growth but What's Next? - AOL.com
Loomis Sayles & Co. L P Sells 37,198 Shares of Doximity, Inc. $DOCS - MarketBeat
Legal & General Group Plc Grows Stake in Doximity, Inc. $DOCS - MarketBeat
Elo Mutual Pension Insurance Co Has $1.01 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Bought by Rhumbline Advisers - MarketBeat
Swiss National Bank Raises Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Here's Why Doximity (DOCS) is a Strong Growth Stock - sharewise.com
Jefferies Financial Group Inc. Increases Holdings in Doximity, Inc. $DOCS - MarketBeat
How supply chain issues affect Doximity Inc. stock2025 Earnings Surprises & Weekly Top Gainers Trade List - BỘ NỘI VỤ
Doximity (DOCS) Q2 2026 Earnings Call Transcript - Nasdaq
Rhenman & Partners Asset Management AB Takes Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. (DOCS) Stock forecasts - Yahoo Finance UK
How Do Investors Really Feel About Doximity Inc? - Benzinga
Doximity upgraded at Raymond James on improving long-term growth visibility - MSN
SG Americas Securities LLC Lowers Stake in Doximity, Inc. $DOCS - MarketBeat
Medical AI Co. Accused Of 'Smear Campaign' Against Rivals - Law360
Universal Beteiligungs und Servicegesellschaft mbH Trims Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Position Trimmed by Sierra Summit Advisors LLC - MarketBeat
Nomura Asset Management Co. Ltd. Acquires Shares of 7,202 Doximity, Inc. $DOCS - MarketBeat
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.22%
6.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):